Overview
This video explains why ICH E6(R3) raises the bar for technology governance in clinical research and how regulated teams can think about systems, controls, and accountability with more confidence.
← Videos
USDM video
Navigating ICH E6(R3) with Confidence
Watch a short overview of ICH E6(R3) and what the updated guidance means for stronger IT governance in clinical research.
1:04 May 15, 2026
Best next step
Watch the short overview, then use the links below to keep moving: explore the related capability, browse more resources, or start a conversation with USDM.
Talk with USDMTrouble with the embedded player? Open the Wistia-hosted video
What to take from it
1
Understand how ICH E6(R3) reinforces the need for clear governance over clinical research technology, data, and digital processes.
2
Learn why clinical teams benefit from stronger alignment between quality expectations, system controls, vendor oversight, and operational execution.
3
Identify where your organization may need to strengthen documentation, traceability, and inspection readiness as clinical research technology evolves.
Keep going
Regulatory Compliance
Explore how USDM helps life sciences teams interpret regulatory expectations and turn them into practical operating controls.
Learn MoreGovernance
See how stronger governance supports risk management, oversight, and confident adoption of regulated technology.
Learn MoreTalk with USDM
Start a conversation about ICH E6(R3), clinical research technology governance, or inspection readiness.
Let's Talk